China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 31.3 CNY -2.43% Market Closed
Market Cap: 15.8B CNY
Have any thoughts about
China Resources Boya Bio pharmaceutical Group Co Ltd?
Write Note

Relative Value

The Relative Value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is 33.45 CNY. Compared to the current market price of 31.3 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is Undervalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
33.45 CNY
Undervaluation 6%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
6
vs Industry
53
Median 3Y
6.3
Median 5Y
6
Industry
8.1
Forward
8.3
vs History
11
vs Industry
2
Median 3Y
42.2
Median 5Y
43.1
Industry
23
Forward
27.8
vs History
14
vs Industry
6
Median 3Y
24.7
Median 5Y
23.1
Industry
23.4
vs History
11
vs Industry
5
Median 3Y
30.6
Median 5Y
30.6
Industry
27.3
vs History
82
vs Industry
38
Median 3Y
2.3
Median 5Y
2.5
Industry
2.6
vs History
25
vs Industry
53
Median 3Y
4.6
Median 5Y
4.9
Industry
8.1
Forward
5.5
vs History
42
vs Industry
40
Median 3Y
8.5
Median 5Y
8.5
Industry
9.6
vs History
9
vs Industry
2
Median 3Y
28.5
Median 5Y
29.8
Industry
4.3
Forward
13.5
vs History
9
vs Industry
2
Median 3Y
28.5
Median 5Y
29.8
Industry
3.8
Forward
16.3
vs History
20
vs Industry
7
Median 3Y
17.6
Median 5Y
17.6
Industry
6
vs History
17
vs Industry
6
Median 3Y
21.2
Median 5Y
19.8
Industry
3.8
vs History
34
vs Industry
31
Median 3Y
4.3
Median 5Y
4
Industry
4.8

Multiples Across Competitors

Competitors Multiples
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
15.8B CNY 7.9 69.4 48.3 48.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Average P/E: 188.1
69.4
208%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Average EV/EBITDA: 22.2
48.3
85%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Average EV/EBIT: 26.8
48.3
44%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top